Review papers featuring developments related to the therapeutic implications of CD44 [9,11,12,13], its role in chemoresistance [14] and metastasis [7,15], its potential role in diagnosis [10,16,17], and its role in glioblastoma multiforme [18] have been published. This evidence concerns the gene CD44 and glioblastoma.